S 41
115th Congress
Senate
Health
Health care costs and insurance
Inflation and prices
Medicare
Prescription drugs
Public contracts and procurement
Medicare Prescription Drug Price Negotiation Act of 2017
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 5, 2017
Read twice and referred to the Committee on Finance.
Jan 5, 2017
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Medicare Prescription Drug Price Negotiation Act of 2017
This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.
What's happening now
Read twice and referred to the Committee on Finance.
Related & companion bills
3
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 41: Medicare Prescription Drug Price Negotiation Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-S-41/
"S. 41: Medicare Prescription Drug Price Negotiation Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-41/.
S. 41, 115th Cong. (2026), https://openamerica.io/bill/115-S-41/.
[S. 41: Medicare Prescription Drug Price Negotiation Act of 2017](https://openamerica.io/bill/115-S-41/)